Saturday, October 1, 2022


Biotechnology News Magazine

Sphere Fluidics Strengthens Commercial Team

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Sphere Fluidics, a company developing single-cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed three new hires to its commercial team.

Evelyn Stevenson and Ravi Girdhar join as Director of Product Management and Director of Sales (EMEA), respectively, alongside Denise Emsden as Vice-President of People and Organizational Development. Following the closure of a £26 million GBP (c. $36 million USD) funding round in 20211, the appointments support the Company’s next stage of development to expand product research and development, international operations, and sales in key global markets.

Evelyn Stevenson, BSc, is a global commercial leader with over 20 years’ experience within the life sciences market from companies such as Azenta Life Sciences, Lonza and Thermo Fisher Scientific.  Evelyn has extensive experience in business development and managing strategic relationships (both internal and external) to ensure product portfolio strategies are highly aligned to current and future business needs. Evelyn commented, “We have a fantastic opportunity to expand our technology into new markets, have a very exciting product pipeline and a great team behind us”.

Ravi Girdhar, MChem, joins Sphere Fluidics as Director of Sales, EMEA. Over the past decade, Ravi has held various commercial positions within GE Healthcare, Thermo Fisher Scientific, and most recently at Gyros Protein Technologies. Ravi stated, “It is an exciting time to join the Sphere Fluidics family as it has become a key emerging player in the single-cell analysis research using its patented picodroplet technology. I am thrilled to be a part of the Company’s commercial expansion plans as it continues its ongoing success with an innovative product portfolio and pipeline to help accelerate biopharmaceutical discovery”.

Denise Emsden, FCIPD NEBOSH, joins Sphere Fluidics as VP of People and Organizational Development. Denise is an accomplished Human Resources professional with significant commercial acumen. Experience in working within diverse industries, including life sciences (Abcam, Mundipharma), FMCG (Sainsburys), and Elite Sports (Juddmonte), ensures a balanced, pragmatic, and considered approach is taken. Denise noted, “I am very excited to join Sphere Fluidics at this point in their evolution. The opportunity to support the organization to attract, develop, engage, and retain the best talent to achieve our strategic goals is incredibly compelling for me”.

Dr Frank F Craig, CEO, of Sphere Fluidics, said “This expansion is funded by our recent $40 million fundraise which will help drive the business to greater success. We have also hired some excellent technical and operations staff and are currently also hiring several other senior managers to help develop the commercial and financial teams. These hires, plus a plan for a new facility, demonstrates this pivotal time for the business”.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine